Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure

Blood (2016) 127 (13): 1656–1665.

https://doi.org/10.1182/blood-2015-10-676924

Published: 2016

Includes: Supplemental data

Journal Articles

Natural history of transient myeloproliferative disorder clinically diagnosed in Down syndrome neonates: a report from the Children's Oncology Group Study A2971

Alan S. Gamis, Todd A. Alonzo, Robert B. Gerbing, Joanne M. Hilden, April D. Sorrell, Mukta Sharma, Thomas W. Loew, Robert J. Arceci, Dorothy Barnard, John Doyle, Gita Massey, John Perentesis, Yaddanapudi Ravindranath, Jeffrey Taub, Franklin O. Smith

Blood (2011) 118 (26): 6752–6759.

https://doi.org/10.1182/blood-2011-04-350017

Published: 2011

Includes: Supplemental data

Journal Articles

Treatment of Steroid-Resistant Graft-Versus-Host Disease with Monoclonal Antibodies in Children.

Tal Schechter, MD, Samina Afzal, MD, Yaron Finkelstein, MD, Gideon Koren, MD, John Doyle, MD, Laura Lee Dupuis, MScPhm

Blood (2006) 108 (11): 5310.

https://doi.org/10.1182/blood.V108.11.5310.5310

Published: 2006

Journal Articles

Outcome of Hematopoietic Stem Cell Transplantation for Pediatric Acute Lymphoblastic Leukemia in Third Complete Remission (CR3): A Vital Role for Graft-Versus-Host-Disease/Graft-Versus-Leukemia Effect in Survival.

Adam Gassas, MD, Kashif Ishaqi, MD, John Doyle, MD

Blood (2006) 108 (11): 3667.

https://doi.org/10.1182/blood.V108.11.3667.3667

Published: 2006

Journal Articles

Important Role for Absolute Lymphocyte Count in Predicting Risk of Relapse in Pediatric Acute Lymphoblastic Leukemia Post Allogeneic Hematopoietic Stem Cell Transplantation.

Mohammed Kashif Ishaqi, MD, Samina Afzal, MD, Annie Dupuis, PhD, John Doyle, MD, Adam Gassas, MD

Blood (2006) 108 (11): 3669.

https://doi.org/10.1182/blood.V108.11.3669.3669

Published: 2006

Journal Articles

Determination of a Limited Sampling Strategy for IV Busulfan Dose Individualization in Children.

Cathryn Sibbald, Tal Schecter, MD, John Doyle, MD, L. Lee Dupuis, MScPhm

Blood (2006) 108 (11): 2942.

https://doi.org/10.1182/blood.V108.11.2942.2942

Published: 2006

Journal Articles

Intravenous Busulfan: Pharmacokinetic Disposition and Clinical Outcomes in Children Undergoing Hematopoietic Stem Cell Transplant.

Tal Schechter, MD, Yaron Finkelstein, MD, John Doyle, MD, Zulfikaral Verjee, PhD, Gideon Koren, MD, Lee Dupuis, MScPhm

Blood (2005) 106 (11): 1760.

https://doi.org/10.1182/blood.V106.11.1760.1760

Published: 2005

Journal Articles

Stem Cell Transplantation from Mismatched Related Donors for Paediatric Haematological Disorders : The Hospital for Sick Children, Toronto, Experience.

Gary Nicolin, MD, Prabodh Das, MD, Elizabeth McDougall, Adam Gassas, MD, Lillian Sung, MD, Wendy Lau, MD, E. Fred Saunders, MD, John Doyle, MD, Stan Calderwood, MD

Blood (2004) 104 (11): 5168.

https://doi.org/10.1182/blood.V104.11.5168.5168

Published: 2004

Journal Articles

Outcome of Stem Cell Transplantation for Pediatric Acute Lymphoblastic Leukemia. A Comparison of Cyclophosphamide and Total Body Irradiation Versus VP16 and Total Body Irradiation Conditioning Regimens.

Adam Gassas, MD, Lillian Sung, MD, Fred Saunders, MD, John Doyle, MD

Blood (2004) 104 (11): 102.

https://doi.org/10.1182/blood.V104.11.102.102

Published: 2004

Journal Articles

Early hematopoietic reconstitution after clinical stem cell transplantation: evidence for stochastic stem cell behavior and limited acceleration in telomere loss

Ian Thornley, Robert Sutherland, Robert Wynn, Rakash Nayar, Lillian Sung, George Corpus, Thomas Kiss, Jeff Lipton, John Doyle, Fred Saunders, Suzanne Kamel-Reid, Melvin Freedman, Hans Messner

Blood (2002) 99 (7): 2387–2396.

https://doi.org/10.1182/blood.V99.7.2387

Published: 2002

NARROW

Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure

Natural history of transient myeloproliferative disorder clinically diagnosed in Down syndrome neonates: a report from the Children's Oncology Group Study A2971

Treatment of Steroid-Resistant Graft-Versus-Host Disease with Monoclonal Antibodies in Children.

Outcome of Hematopoietic Stem Cell Transplantation for Pediatric Acute Lymphoblastic Leukemia in Third Complete Remission (CR3): A Vital Role for Graft-Versus-Host-Disease/Graft-Versus-Leukemia Effect in Survival.

Important Role for Absolute Lymphocyte Count in Predicting Risk of Relapse in Pediatric Acute Lymphoblastic Leukemia Post Allogeneic Hematopoietic Stem Cell Transplantation.

Determination of a Limited Sampling Strategy for IV Busulfan Dose Individualization in Children.

Intravenous Busulfan: Pharmacokinetic Disposition and Clinical Outcomes in Children Undergoing Hematopoietic Stem Cell Transplant.

Stem Cell Transplantation from Mismatched Related Donors for Paediatric Haematological Disorders : The Hospital for Sick Children, Toronto, Experience.

Outcome of Stem Cell Transplantation for Pediatric Acute Lymphoblastic Leukemia. A Comparison of Cyclophosphamide and Total Body Irradiation Versus VP16 and Total Body Irradiation Conditioning Regimens.

Early hematopoietic reconstitution after clinical stem cell transplantation: evidence for stochastic stem cell behavior and limited acceleration in telomere loss

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only